Philip Hawke Selected Research

Philip Hawke Research Topics

3	Esophageal Neoplasms (Esophageal Cancer) 04/2024 - 08/2022
2	Neoplasms (Cancer) 04/2024 - 08/2022
2	Fibrosis (Cirrhosis) 03/2024 - 01/2022
2	Hypertrophy 05/2023 - 01/2022
1	Inflammation (Inflammations) 04/2024
1	Chronic Subdural Hematoma 06/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2023
1	Cardiomegaly (Heart Hypertrophy) 05/2023
1	Heart Failure 05/2023
1	Esophageal Squamous Cell Carcinoma 01/2023
1	Malnutrition (Nutritional Deficiencies) 01/2023
1	Cardiotoxicity 01/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022
1	Sarcopenia 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2021
1	Glomerulonephritis 10/2021
1	Dry Socket (Alveolar Osteitis) 01/2021
1	Pain (Aches) 01/2021
1	Chronic Hepatitis C 12/2016
1	Infections 12/2016

2	Serum AlbuminIBA 04/2024 - 10/2021
2	Histones (Histone)IBA 03/2024 - 01/2022
1	GSK3235025IBA 03/2024
1	Arginine (L-Arginine)FDA Link 03/2024
1	Tranexamic Acid (AMCA)FDA Link 06/2023
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 05/2023
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 05/2023
1	shogaolIBA 05/2023
1	PhytochemicalsIBA 05/2023
1	4-azidosalicylic acid-phosphatidylserineIBA 08/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	AnthracyclinesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2021
1	loxoprofen (CS 600)IBA 01/2021
1	Oxytetracycline (Terramycin)FDA Link 01/2021
1	Ointments (Pastes)IBA 01/2021
1	SodiumIBA 01/2021
1	TabletsIBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	InterferonsIBA 12/2016
1	Ribavirin (Virazole)FDA LinkGeneric 12/2016

3	Esophagectomy 04/2024 - 08/2022
1	Craniotomy 06/2023
1	Therapeutics 05/2023
1	Neoadjuvant Therapy 01/2023
1	Drug Therapy (Chemotherapy) 08/2022
1	Sutures (Suture) 01/2021
1	Tooth Extraction (Tooth Extractions) 01/2021